Related references
Note: Only part of the references are listed.Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy
Koichi Yanaba et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2016)
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
L. Bracci et al.
CELL DEATH AND DIFFERENTIATION (2014)
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
Andrea Gallamini et al.
HAEMATOLOGICA (2014)
FDG-PET Response-adapted Therapy Is 18F-Fluorodeoxyglucose Positron Emission Tomography a Safe Predictor for a Change of Therapy?
Martin Hutchings
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F. Barrington et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
In Vivo Treatment Sensitivity Testing With Positron Emission Tomography/Computed Tomography After One Cycle of Chemotherapy for Hodgkin Lymphoma
Martin Hutchings et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Omitting Radiotherapy in Early Positron Emission Tomography-Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial
John M. M. Raemaekers et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis
Morten Stilund et al.
PLOS ONE (2014)
The microenvironment in classical Hodgkin lymphoma: An actively shaped and essential tumor component
Yuxuan Liu et al.
SEMINARS IN CANCER BIOLOGY (2014)
Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma
Maike Sauer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma
Jing Ouyang et al.
BLOOD (2013)
Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma
Kimberley Jones et al.
CLINICAL CANCER RESEARCH (2013)
Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma
Preethi Reddy Marri et al.
CLINICAL CANCER RESEARCH (2013)
Altered galectin-1 serum levels in patients diagnosed with high-grade glioma
Tina Verschuere et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
The Macrophage-Specific Serum Marker, Soluble CD163, Is Increased in Obesity and Reduced After Dietary-Induced Weight Loss
Karen Fjeldborg et al.
OBESITY (2013)
Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management
Stephen M. Ansell
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma
Wouter J. Plattel et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Hodgkin lymphoma
Ralf Küppers et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22
Marijke Niens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
The determination of the levels of circulating galectin-1 and-3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy
Sven Saussez et al.
ORAL ONCOLOGY (2008)
Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease
Sven Saussez et al.
THYROID (2008)
Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:: A report from a joint Italian-Danish study
Andrea Gallamini et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma:: A study from the Groupe d'Etude des Lymphomes de l'Adulte
Rene-Olivier Casasnovas et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma
Malik E. Juweid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: Potential for a prognostic factor
MR Weihrauch et al.
CANCER RESEARCH (2005)
Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure
A Hiraoka et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma
R Zanotti et al.
ANNALS OF ONCOLOGY (2002)
Share Paper
